MD-2 is required for disulfide HMGB1-dependent TLR4 signaling

Huan Yang, Haichao Wang, Zhongliang Ju, Ahmed A. Ragab, Peter Lundbäck, Wei Long, Sergio I. Valdes-Ferrer, Mingzhu He, John P. Pribis, Jianhua Li, Ben Lu, Domokos Gero, Csaba Szabo, Daniel J. Antoine, Helena E. Harris, Doug T. Golenbock, Jianmin Meng, Jesse Roth, Sangeeta S. Chavan, Ulf AnderssonTimothy R. Billiar, Kevin J. Tracey, Yousef Al-Abed

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Innate immune receptors for pathogen-and damage-associated molecular patterns (PAMPs and DAMPs) orchestrate inflammatory responses to infection and injury. Secreted by activated immune cells or passively released by damaged cells, HMGB1 is subjected to redox modification that distinctly influences its extracellular functions. Previously, it was unknown how the TLR4 signalosome distinguished between HMGB1 isoforms. Here we demonstrate that the extracellular TLR4 adaptor, myeloid differentiation factor 2 (MD-2), binds specifically to the cytokine-inducing disulfide isoform of HMGB1, to the exclusion of other isoforms. Using MD-2-deficient mice, as well as MD-2 silencing in macrophages, we show a requirement for HMGB1-dependent TLR4 signaling. By screening HMGB1 peptide libraries, we identified a tetramer (FSSE, designated P5779) as a specific MD-2 antagonist preventing MD-2-HMGB1 interaction and TLR4 signaling. P5779 does not interfere with lipopolysaccharide-induced cytokine/chemokine production, thus preserving PAMP-mediated TLR4-MD-2 responses. Furthermore, P5779 can protect mice against hepatic ischemia/reperfusion injury, chemical toxicity, and sepsis. These findings reveal a novel mechanism by which innate systems selectively recognize specific HMGB1 isoforms. The results may direct toward strategies aimed at attenuating DAMP-mediated inflammation while preserving antimicrobial immune responsiveness.

Original languageEnglish (US)
Pages (from-to)5-14
Number of pages10
JournalJournal of Experimental Medicine
Volume212
Issue number1
DOIs
StatePublished - 2015

Fingerprint

HMGB1 Protein
Disulfides
Protein Isoforms
Cytokines
Peptide Library
Reperfusion Injury
Chemokines
Oxidation-Reduction
Lipopolysaccharides
Sepsis
Macrophages
Inflammation
Liver
Wounds and Injuries
Infection

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Yang, H., Wang, H., Ju, Z., Ragab, A. A., Lundbäck, P., Long, W., ... Al-Abed, Y. (2015). MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. Journal of Experimental Medicine, 212(1), 5-14. https://doi.org/10.1084/jem.20141318

MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. / Yang, Huan; Wang, Haichao; Ju, Zhongliang; Ragab, Ahmed A.; Lundbäck, Peter; Long, Wei; Valdes-Ferrer, Sergio I.; He, Mingzhu; Pribis, John P.; Li, Jianhua; Lu, Ben; Gero, Domokos; Szabo, Csaba; Antoine, Daniel J.; Harris, Helena E.; Golenbock, Doug T.; Meng, Jianmin; Roth, Jesse; Chavan, Sangeeta S.; Andersson, Ulf; Billiar, Timothy R.; Tracey, Kevin J.; Al-Abed, Yousef.

In: Journal of Experimental Medicine, Vol. 212, No. 1, 2015, p. 5-14.

Research output: Contribution to journalArticle

Yang, H, Wang, H, Ju, Z, Ragab, AA, Lundbäck, P, Long, W, Valdes-Ferrer, SI, He, M, Pribis, JP, Li, J, Lu, B, Gero, D, Szabo, C, Antoine, DJ, Harris, HE, Golenbock, DT, Meng, J, Roth, J, Chavan, SS, Andersson, U, Billiar, TR, Tracey, KJ & Al-Abed, Y 2015, 'MD-2 is required for disulfide HMGB1-dependent TLR4 signaling', Journal of Experimental Medicine, vol. 212, no. 1, pp. 5-14. https://doi.org/10.1084/jem.20141318
Yang, Huan ; Wang, Haichao ; Ju, Zhongliang ; Ragab, Ahmed A. ; Lundbäck, Peter ; Long, Wei ; Valdes-Ferrer, Sergio I. ; He, Mingzhu ; Pribis, John P. ; Li, Jianhua ; Lu, Ben ; Gero, Domokos ; Szabo, Csaba ; Antoine, Daniel J. ; Harris, Helena E. ; Golenbock, Doug T. ; Meng, Jianmin ; Roth, Jesse ; Chavan, Sangeeta S. ; Andersson, Ulf ; Billiar, Timothy R. ; Tracey, Kevin J. ; Al-Abed, Yousef. / MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. In: Journal of Experimental Medicine. 2015 ; Vol. 212, No. 1. pp. 5-14.
@article{aeab73e8edca46629bbd45cccd1c7ad2,
title = "MD-2 is required for disulfide HMGB1-dependent TLR4 signaling",
abstract = "Innate immune receptors for pathogen-and damage-associated molecular patterns (PAMPs and DAMPs) orchestrate inflammatory responses to infection and injury. Secreted by activated immune cells or passively released by damaged cells, HMGB1 is subjected to redox modification that distinctly influences its extracellular functions. Previously, it was unknown how the TLR4 signalosome distinguished between HMGB1 isoforms. Here we demonstrate that the extracellular TLR4 adaptor, myeloid differentiation factor 2 (MD-2), binds specifically to the cytokine-inducing disulfide isoform of HMGB1, to the exclusion of other isoforms. Using MD-2-deficient mice, as well as MD-2 silencing in macrophages, we show a requirement for HMGB1-dependent TLR4 signaling. By screening HMGB1 peptide libraries, we identified a tetramer (FSSE, designated P5779) as a specific MD-2 antagonist preventing MD-2-HMGB1 interaction and TLR4 signaling. P5779 does not interfere with lipopolysaccharide-induced cytokine/chemokine production, thus preserving PAMP-mediated TLR4-MD-2 responses. Furthermore, P5779 can protect mice against hepatic ischemia/reperfusion injury, chemical toxicity, and sepsis. These findings reveal a novel mechanism by which innate systems selectively recognize specific HMGB1 isoforms. The results may direct toward strategies aimed at attenuating DAMP-mediated inflammation while preserving antimicrobial immune responsiveness.",
author = "Huan Yang and Haichao Wang and Zhongliang Ju and Ragab, {Ahmed A.} and Peter Lundb{\"a}ck and Wei Long and Valdes-Ferrer, {Sergio I.} and Mingzhu He and Pribis, {John P.} and Jianhua Li and Ben Lu and Domokos Gero and Csaba Szabo and Antoine, {Daniel J.} and Harris, {Helena E.} and Golenbock, {Doug T.} and Jianmin Meng and Jesse Roth and Chavan, {Sangeeta S.} and Ulf Andersson and Billiar, {Timothy R.} and Tracey, {Kevin J.} and Yousef Al-Abed",
year = "2015",
doi = "10.1084/jem.20141318",
language = "English (US)",
volume = "212",
pages = "5--14",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "1",

}

TY - JOUR

T1 - MD-2 is required for disulfide HMGB1-dependent TLR4 signaling

AU - Yang, Huan

AU - Wang, Haichao

AU - Ju, Zhongliang

AU - Ragab, Ahmed A.

AU - Lundbäck, Peter

AU - Long, Wei

AU - Valdes-Ferrer, Sergio I.

AU - He, Mingzhu

AU - Pribis, John P.

AU - Li, Jianhua

AU - Lu, Ben

AU - Gero, Domokos

AU - Szabo, Csaba

AU - Antoine, Daniel J.

AU - Harris, Helena E.

AU - Golenbock, Doug T.

AU - Meng, Jianmin

AU - Roth, Jesse

AU - Chavan, Sangeeta S.

AU - Andersson, Ulf

AU - Billiar, Timothy R.

AU - Tracey, Kevin J.

AU - Al-Abed, Yousef

PY - 2015

Y1 - 2015

N2 - Innate immune receptors for pathogen-and damage-associated molecular patterns (PAMPs and DAMPs) orchestrate inflammatory responses to infection and injury. Secreted by activated immune cells or passively released by damaged cells, HMGB1 is subjected to redox modification that distinctly influences its extracellular functions. Previously, it was unknown how the TLR4 signalosome distinguished between HMGB1 isoforms. Here we demonstrate that the extracellular TLR4 adaptor, myeloid differentiation factor 2 (MD-2), binds specifically to the cytokine-inducing disulfide isoform of HMGB1, to the exclusion of other isoforms. Using MD-2-deficient mice, as well as MD-2 silencing in macrophages, we show a requirement for HMGB1-dependent TLR4 signaling. By screening HMGB1 peptide libraries, we identified a tetramer (FSSE, designated P5779) as a specific MD-2 antagonist preventing MD-2-HMGB1 interaction and TLR4 signaling. P5779 does not interfere with lipopolysaccharide-induced cytokine/chemokine production, thus preserving PAMP-mediated TLR4-MD-2 responses. Furthermore, P5779 can protect mice against hepatic ischemia/reperfusion injury, chemical toxicity, and sepsis. These findings reveal a novel mechanism by which innate systems selectively recognize specific HMGB1 isoforms. The results may direct toward strategies aimed at attenuating DAMP-mediated inflammation while preserving antimicrobial immune responsiveness.

AB - Innate immune receptors for pathogen-and damage-associated molecular patterns (PAMPs and DAMPs) orchestrate inflammatory responses to infection and injury. Secreted by activated immune cells or passively released by damaged cells, HMGB1 is subjected to redox modification that distinctly influences its extracellular functions. Previously, it was unknown how the TLR4 signalosome distinguished between HMGB1 isoforms. Here we demonstrate that the extracellular TLR4 adaptor, myeloid differentiation factor 2 (MD-2), binds specifically to the cytokine-inducing disulfide isoform of HMGB1, to the exclusion of other isoforms. Using MD-2-deficient mice, as well as MD-2 silencing in macrophages, we show a requirement for HMGB1-dependent TLR4 signaling. By screening HMGB1 peptide libraries, we identified a tetramer (FSSE, designated P5779) as a specific MD-2 antagonist preventing MD-2-HMGB1 interaction and TLR4 signaling. P5779 does not interfere with lipopolysaccharide-induced cytokine/chemokine production, thus preserving PAMP-mediated TLR4-MD-2 responses. Furthermore, P5779 can protect mice against hepatic ischemia/reperfusion injury, chemical toxicity, and sepsis. These findings reveal a novel mechanism by which innate systems selectively recognize specific HMGB1 isoforms. The results may direct toward strategies aimed at attenuating DAMP-mediated inflammation while preserving antimicrobial immune responsiveness.

UR - http://www.scopus.com/inward/record.url?scp=84921328278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921328278&partnerID=8YFLogxK

U2 - 10.1084/jem.20141318

DO - 10.1084/jem.20141318

M3 - Article

C2 - 25559892

AN - SCOPUS:84921328278

VL - 212

SP - 5

EP - 14

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 1

ER -